Yuxia Pan
Key Laboratory Of Hematology
Shijiazhuang, China
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: August 20, 2023
The histone deacetylase inhibitor chidamide improve the sensitivity of chronic myelogenous leukemia drug-resistant cells to imatinib by regulating PTPN6.
Journal: Minerva medica
Published: May 18, 2023
The different variant allele frequencies of type I/type II mutations and the distinct molecular landscapes in CALR-mutant essential thrombocythaemia and primary myelofibrosis.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 24, 2022
HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia.
Journal: Frontiers in oncology
Published: March 19, 2021
JNK Signaling Pathway Suppresses LPS-Mediated Apoptosis of HK-2 Cells by Upregulating NGAL.
Journal: International journal of inflammation
Published: October 31, 2019
The Reparative Effects of Human Adipose-Derived Mesenchymal Stem Cells in the Chemotherapy-Damaged Thymus.
Journal: Stem cells and development
Published: December 05, 2018
Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia.
Journal: British journal of haematology
Published: November 14, 2016
Imatinib is effective in a 12-month-old boy with chronic myelogenous leukemia: case report and literature review
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: July 14, 2015
SHP-1 gene in the disease progression of chronic myeloid leukemia
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 30, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026